Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease: A Randomized, Controlled Trial

NCT02193750 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT02193750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02193750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease: A Randomized, Controlled Trial
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Terminated
Start date
August 31, 2015
Completion date
September 30, 2020
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease